Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy
INTRODUCTION
Tofacitinib is a Janus kinase (JAK) 1-3 inhibitor first U.S. Food and Drug Administration (FDA) approved in 2012 for rheumatoid arthritis, with subsequent approval for psoriatic arthritis, ulcerative colitis, polyarticular course juvenile idiopathic arthritis, and ankylosing spondylitis in 2017, 2018, 2020, and 2021, respectively.1,2 In the last several years, oral tofacitinib …
INTRODUCTION
Tofacitinib is a Janus kinase (JAK) 1-3 inhibitor first U.S. Food and Drug Administration (FDA) approved in 2012 for rheumatoid arthritis, with subsequent approval for psoriatic arthritis, ulcerative colitis, polyarticular course juvenile idiopathic arthritis, and ankylosing spondylitis in 2017, 2018, 2020, and 2021, respectively.1,2 In the last several years, oral tofacitinib … Continue reading "Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy"
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Vishal A. Patel (fellowship trained Mohs micrographic surgeon who serves as Director of Cutaneous Oncology at the GW Cancer Center and Director of Dermatologic Surgery at the GW Department of Dermatology) about routine skin cancer checks. Watch as he provides insight on this complex questio … 
Atopic dermatitis (AD) is a chronic skin condition characterized by pruritus, inflammation, and acute flare-ups of eczematous lesions over dry skin.1 The wide range of clinical manifestations, the visible nature of the disease, and the intense itching significantly affects patients’ quality of life.2 Up to 80% of children with AD experience sleep disturbances.3 Sixty-seven percent of children … 
Dr. Vishal Patel (Assistant Professor of Dermatology and Director of the Cutaneous Oncology Program at George Washington University School of Medicine and Health Sciences) gave a thought-provoking talk at the 2022 ODAC Dermatology, Aesthetic & Surgical Conference about something we do nearly every day as dermatologists – full body skin exams. He started by reviewing the rising epidemic of sk … 
Hair loss is making dermatology news in the consumer press after recent news coverage of oral minoxidil. In addition, stories this month address treatments that work for women with thinning hair and answer how much hair is normal to lose.
Get a jumpstart on answering your patients’ questions by knowing what they are reading. Review this list of articles and be ready for your next office visit … 